Literature DB >> 31843861

Promoting Optimal Development: Identifying Infants and Young Children With Developmental Disorders Through Developmental Surveillance and Screening.

Paul H Lipkin1, Michelle M Macias2.   

Abstract

Early identification and intervention for developmental disorders are critical to the well-being of children and are the responsibility of pediatric professionals as an integral function of the medical home. This report models a universal system of developmental surveillance and screening for the early identification of conditions that affect children's early and long-term development and achievement, followed by ongoing care. These conditions include autism, deafness/hard-of-hearing, intellectual and motor disabilities, behavioral conditions, and those seen in other medical conditions. Developmental surveillance is supported at every health supervision visit, as is as the administration of standardized screening tests at the 9-, 18-, and 30-month visits. Developmental concerns elicited on surveillance at any visit should be followed by standardized developmental screening testing or direct referral to intervention and specialty medical care. Special attention to surveillance is recommended at the 4- to 5-year well-child visit, prior to entry into elementary education, with screening completed if there are any concerns. Developmental surveillance includes bidirectional communication with early childhood professionals in child care, preschools, Head Start, and other programs, including home visitation and parenting, particularly around developmental screening. The identification of problems should lead to developmental and medical evaluations, diagnosis, counseling, and treatment, in addition to early developmental intervention. Children with diagnosed developmental disorders are identified as having special health care needs, with initiation of chronic condition management in the pediatric medical home.
Copyright © 2020 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2019        PMID: 31843861     DOI: 10.1542/peds.2019-3449

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  48 in total

1.  Do Autism-Specific and General Developmental Screens Have Complementary Clinical Value?

Authors:  Raymond Sturner; Paul Bergmann; Barbara Howard; Kerry Bet; Lydia Stewart-Artz; Shana Attar
Journal:  J Autism Dev Disord       Date:  2022-05-17

2.  Cognitive predictors of Social processing in congenital atypical development.

Authors:  Elisabetta Ferrari; Niccolò Butti; Chiara Gagliardi; Romina Romaniello; Renato Borgatti; Cosimo Urgesi
Journal:  J Autism Dev Disord       Date:  2022-06-21

3.  Fetal Brain Volume Predicts Neurodevelopment in Congenital Heart Disease.

Authors:  Cynthia M Ortinau; Caitlin K Rollins; Anjali Sadhwani; David Wypij; Valerie Rofeberg; Ali Gholipour; Maggie Mittleman; Julia Rohde; Clemente Velasco-Annis; Johanna Calderon; Kevin G Friedman; Wayne Tworetzky; P Ellen Grant; Janet S Soul; Simon K Warfield; Jane W Newburger
Journal:  Circulation       Date:  2022-02-10       Impact factor: 29.690

4.  Comparative Accuracy of Developmental Screening Questionnaires.

Authors:  R Christopher Sheldrick; Susan Marakovitz; Daryl Garfinkel; Alice S Carter; Ellen C Perrin
Journal:  JAMA Pediatr       Date:  2020-04-01       Impact factor: 16.193

5.  A Taxonomy of Reported Harms in Pediatric Autism Spectrum Disorder Screening: Provider and Parent Perspectives.

Authors:  Marisa Petruccelli; Leah Ramella; Ana J Schaefer; R Christopher Sheldrick; Alice S Carter; Abbey Eisenhower; Sarabeth Broder-Fingert; Thomas I Mackie
Journal:  J Autism Dev Disord       Date:  2021-03-22

6.  Are Developmental Monitoring and Screening Better Together for Early Autism Identification Across Race and Ethnic Groups?

Authors:  Brian Barger; Catherine Rice; Teal Benevides; Ashley Salmon; Sonia Sanchez-Alvarez; Daniel Crimmins
Journal:  J Autism Dev Disord       Date:  2021-03-05

7.  Factors Associated with Self-regulation in a Nationally Representative Sample of Children Ages 3-5 Years: United States, 2016.

Authors:  Angelika H Claussen; Lara R Robinson; Jennifer W Kaminski; Sana Charania; Joseph R Holbrook; Marvin So; Reem Ghandour; Camille Smith; Ashley Satterfield-Nash; Georgina Peacock; Coleen Boyle
Journal:  Matern Child Health J       Date:  2020-11-21

8.  Improving autism and developmental screening and referral in US primary care practices serving Latinos.

Authors:  Katharine E Zuckerman; Alison E Chavez; Laura Wilson; Katie Unger; Colleen Reuland; Katrina Ramsey; Margaret King; Julie Scholz; Eric Fombonne
Journal:  Autism       Date:  2020-09-14

9.  Expanding the Vision of Quality and Safety in Genomic Medicine.

Authors:  Katrina A Armstrong
Journal:  J Gen Intern Med       Date:  2021-08-06       Impact factor: 5.128

10.  Pediatric Neurodevelopmental Delays in Children 0 to 5 Years of Age With Sickle Cell Disease: A Systematic Literature Review.

Authors:  La'Kita M J Knight; Allison A King; John J Strouse; Paula Tanabe
Journal:  J Pediatr Hematol Oncol       Date:  2021-04-01       Impact factor: 1.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.